Caplin Point Laboratories Limited — Losartan Exporter Profile
Indian Pharmaceutical Exporter · #11 for Losartan · $7.3M export value · DGFT Verified
Caplin Point Laboratories Limited is the #11 Indian exporter of Losartan with $7.3M in export value and 146 verified shipments. Caplin Point Laboratories Limited holds a 2.4% market share in Losartan exports across 8 countries. The company exports 55 pharmaceutical products worth $174.5M across 20 therapeutic categories.
Caplin Point Laboratories Limited — Losartan Export Profile: Buyers & Destinations
Where Does Caplin Point Laboratories Limited Export Losartan?
| Country | Value | Shipments | Share |
|---|---|---|---|
| NICARAGUA | $1.4M | 43 | 37.2% |
| GAUTEMALA | $947.9K | 37 | 26.1% |
| GUATEMALA | $630.7K | 18 | 17.3% |
| ECUADOR | $285.8K | 12 | 7.9% |
| CHILE | $153.9K | 7 | 4.2% |
| EL SALVADOR | $92.4K | 7 | 2.5% |
| DOMINICAN REPULIC | $65.7K | 6 | 1.8% |
| DOMINICAN REPUBLIC | $60.0K | 5 | 1.6% |
| MALI | $32.1K | 9 | 0.9% |
| HONDURAS | $14.3K | 2 | 0.4% |
Caplin Point Laboratories Limited exports Losartan to 10 countries. The largest destination is NICARAGUA accounting for 37.2% of Caplin Point Laboratories Limited's Losartan shipments, followed by GAUTEMALA (26.1%) and GUATEMALA (17.3%). These destinations reflect Caplin Point Laboratories Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Losartan from Caplin Point Laboratories Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| FARMA SOLUTION SOCIEDAD ANONIMA | GUATEMALA | $512.7K | 14 |
| NUEVOS ETICOS NEOETHICALS, S.A. | GAUTEMALA | $508.6K | 17 |
| NEOETHICALS, S.A, | NICARAGUA | $400.7K | 16 |
| NEOETHICALS, S.A | NICARAGUA | $334.1K | 11 |
| NUEVOS ETICOS NEOETHICALS S A | GAUTEMALA | $332.0K | 10 |
| NEOETHICALS S A | NICARAGUA | $304.8K | 8 |
| NEOETHICALS CIA LTDA | ECUADOR | $269.1K | 11 |
| NEOETHICALS S.A | NICARAGUA | $218.9K | 6 |
| NUEVOS ETICOS NEOETHICALS, S A | GAUTEMALA | $132.1K | 6 |
| NEOETHICALS CHILE SPA. | CHILE | $114.2K | 3 |
Caplin Point Laboratories Limited supplies Losartan to 25 buyers globally. The largest buyer is FARMA SOLUTION SOCIEDAD ANONIMA (GUATEMALA), followed by NUEVOS ETICOS NEOETHICALS, S.A. (GAUTEMALA) and NEOETHICALS, S.A, (NICARAGUA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Losartan Export Value and How Much Does Caplin Point Laboratories Limited Contribute?
India exported $143.4M worth of Losartan through 10,898 shipments from 506 suppliers to 141 countries, serving 1,415 buyers globally. Caplin Point Laboratories Limited contributes $7.3M to this total, accounting for 2.4% of India's Losartan exports. Caplin Point Laboratories Limited ships Losartan to 10 countries through 25 buyers.
What Is the Average Shipment Value for Caplin Point Laboratories Limited's Losartan Exports?
Caplin Point Laboratories Limited's average Losartan shipment value is $50.0K per consignment, based on 146 shipments totaling $7.3M. The largest destination is NICARAGUA (37.2% of Caplin Point Laboratories Limited's Losartan exports).
How Does Caplin Point Laboratories Limited Compare to Other Indian Losartan Exporters?
Caplin Point Laboratories Limited ranks #11 among 506 Indian Losartan exporters with a 2.4% market share. The top 3 exporters are ZYDUS LIFESCIENCES LIMITED ($28.1M), MICRO LABS LIMITED ($20.5M), AUROBINDO PHARMA LTD ($13.0M). Caplin Point Laboratories Limited processed 146 shipments to 8 destination countries.
What Losartan Formulations Does Caplin Point Laboratories Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| LOSARTAN POTASSIUM TABLETS USP 50MG | $1.2M | 43 |
| LOSARTAN POTASSIUM TABLETS USP 100MG | $755.0K | 35 |
| LOSARTAN POTASSIUM TABLETS USP 50 MG | $482.8K | 13 |
| LOSARTAN POTASSIUM TABLETS USP 100 MG | $263.7K | 10 |
| LOSARTAN POTASSIUM TABLETS USP 50MG LOSARTAN POTASICO TABLETAS 50MG - ITEM CODE:171001373 | $234.1K | 9 |
| LOSARTAN POTASSIUM TABLETS USP 50MG LOSA | $132.1K | 6 |
| LOSARTAN POTASSIUM TABLETS USP 100MGNOS | $121.7K | 3 |
| LOSARTAN POTASSIUM TABLETS USP 50 MGNOS | $97.2K | 3 |
| LOSARTAN POTASSIUM TABLETS USP 100MG LOSARTAN POTASICO TABLETAS RECUBIERTAS 100MG Losartan potasico usp 100mg ITEM COD | $50.0K | 1 |
| (LOSARTAN POTASSIUM TABLETS USP 50MG | $50.0K | 1 |
Caplin Point Laboratories Limited exports 25 distinct Losartan formulations including tablets, capsules, syrups, and combination drugs. The top formulation is LOSARTAN POTASSIUM TABLETS USP 50MG with 43 shipments worth $1.2M. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
How Does Caplin Point Laboratories Limited Compare to Nearest Losartan Exporters?
Exporters ranked immediately above and below #11 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 3 | CIPLA LIMITED | $9.2M | 184 | 3 | $50.0K |
| 12 | MSN LABORATORIES PRIVATE LIMITED | $7.4M | 410 | 1 | $18.2K |
| 11 | CAPLIN POINT LABORATORIES LIMITED ★ | $7.3M | 146 | 8 | $50.0K |
| 8 | EMIL PHARMACEUTICAL INDUSTRIES PVT LTD | $5.7M | 113 | 2 | $50.0K |
| 14 | AUROBINDO PHARMA LIMITED | $5.1M | 159 | 5 | $32.2K |
Caplin Point Laboratories Limited ranks #11 among 506 Indian Losartan exporters. Average shipment value of $50.0K compared to the market average of $283.3K. The closest competitors by value are CIPLA LIMITED and MSN LABORATORIES PRIVATE LIMITED.
Which Indian Ports Ship Losartan Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 1,020 | 9.4% |
| NHAVA SHEVA SEA (INNSA1) | 946 | 8.7% |
| SAHAR AIR CARGO ACC (INBOM4) | 886 | 8.1% |
| DELHI AIR CARGO ACC (INDEL4) | 702 | 6.4% |
| DELHI AIR | 672 | 6.2% |
| JNPT/ NHAVA SHEVA SEA | 549 | 5.0% |
| MUNDRA SEA | 491 | 4.5% |
| HYDERABAD ICD | 384 | 3.5% |
What Other Cardiovascular Products Does Caplin Point Laboratories Limited Export?
Caplin Point Laboratories Limited also exports these cardiovascular products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Caplin Point Laboratories Limited's Losartan Exports
The global pharmaceutical export landscape is currently navigating several geopolitical challenges that directly impact companies like Caplin Point.
The Israel-Iran conflict has led to disruptions in Red Sea shipping routes, causing maritime carriers to suspend bookings and reroute vessels around the Cape of Good Hope. This has resulted in elongated lead times and increased shipping costs, disproportionately affecting time-sensitive pharmaceutical shipments. Freight charges have surged, with transport costs doubling and additional surcharges ranging from $4,000 to $8,000 per shipment. Such disruptions pose significant risks to the timely delivery of pharmaceuticals, especially those requiring stringent cold-chain logistics. (pharmaceuticalcommerce.com)
In the United States, recent tariff implementations have introduced further complexities. The U.S. administration has imposed broad tariffs on imports from over 60 countries, including India, with rates reaching up to 39%. These tariffs affect a substantial portion of Indian exports to the U.S., including pharmaceuticals, potentially leading to increased costs and competitive disadvantages for Indian exporters. (apnews.com)
The European Union's regulatory landscape is also evolving, with stricter compliance requirements under directives like the Falsified Medicines Directive. Indian pharmaceutical companies must invest in advanced serialization and traceability systems to meet these standards, ensuring continued access to the lucrative EU market.
For Caplin Point, these geopolitical and regulatory developments necessitate strategic adaptations. Diversifying export markets, enhancing supply chain resilience, and investing in compliance infrastructure are critical to mitigating risks and sustaining growth in this volatile environment.
Caplin Point Laboratories Limited — Regulatory Compliance & Quality Standards
The global pharmaceutical industry is witnessing heightened regulatory scrutiny, particularly from agencies like the U.S. FDA and the European Medicines Agency. Compliance with Good Manufacturing Practices (GMP) and other quality standards is imperative for market access.
Caplin Point has proactively addressed these requirements. The company's subsidiary, Caplin Steriles Limited (CSL), has secured an EU GMP renewal and successfully passed audits by regulatory bodies such as the Saudi FDA. These achievements underscore Caplin Point's commitment to maintaining high-quality standards and ensuring compliance with international regulations. (whalesbook.com)
However, the broader Indian pharmaceutical sector faces challenges related to quality and compliance. The U.S. FDA conducted over 200 inspections in India in 2023, with plans to increase this number in subsequent years. Instances of substandard products have led to increased scrutiny, emphasizing the need for continuous quality improvements. (fact.net.in)
For Caplin Point, ongoing investment in quality assurance systems, employee training, and infrastructure upgrades is essential to navigate the evolving regulatory landscape and maintain its competitive edge.
About Caplin Point Laboratories Limited
Caplin Point Laboratories Limited exports 55 products worth $174.5M. Beyond Losartan, top products include Ibuprofen, Diclofenac, Clotrimazole, Potassium, Vitamin. View the complete Caplin Point Laboratories Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Losartan — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Losartan shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Caplin Point Laboratories Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 146 individual customs records matching Caplin Point Laboratories Limited exporting Losartan, covering 25 formulations to 10 countries via 25 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 141+ countries, 1,415+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Losartan Export Data from Caplin Point Laboratories Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Caplin Point Laboratories Limited's Losartan exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Caplin Point Laboratories Limited
Full Company Profile →
55 products · $174.5M total trade · 20 categories
Losartan Stats
Company Overview
Top Products by Caplin Point Laboratories Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Caplin Point Laboratories Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Losartan. For current shipment-level data, contact TransData Nexus.